Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obstructive nephropathy.

S Klahr1

  • 1Department of Internal Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri 63100-1092, USA.

Internal Medicine (Tokyo, Japan)
|June 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of chronic renal disease.

Heart disease (Hagerstown, Md.)·2002
Same author

The role of nitric oxide in hypertension and renal disease progression.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
Same author

Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.

American journal of physiology. Renal physiology·2001
Same author

Urinary tract obstruction.

Seminars in nephrology·2001
Same author

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

American journal of physiology. Renal physiology·2000
Same author

The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease.

Kidney international. Supplement·2000
Same journal

A Possible Case of Drug-induced ANCA-associated Vasculitis Associated with Mirabegron.

Internal medicine (Tokyo, Japan)·2026
Same journal

Microangiopathic Hemolytic Anemia Due to Disseminated Carcinomatosis of the Bone Marrow in Esophageal Adenocarcinoma.

Internal medicine (Tokyo, Japan)·2026
Same journal

Recurrent Sigmoid Diverticulitis Managed with Adjunctive Daiobotanpito: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same journal

Tracheobronchial mucormycosis.

Internal medicine (Tokyo, Japan)·2026
Same journal

A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor Treatment.

Internal medicine (Tokyo, Japan)·2026
Same journal

Acute Spinal Calcium Pyrophosphate Dehydrate Deposition Disease.

Internal medicine (Tokyo, Japan)·2026
See all related articles

Obstructive nephropathy, a common and reversible condition affecting all ages, can impair kidney function. Early intervention is key to managing urinary tract obstruction and preventing long-term damage like renal fibrosis.

Area of Science:

  • Nephrology
  • Urology
  • Renal Pathophysiology

Background:

  • Obstructive nephropathy is a prevalent condition affecting patients across all age groups.
  • Urinary tract obstruction can result from various functional or anatomical lesions.
  • This condition can lead to decreased renal blood flow, glomerular filtration rate, and tubular dysfunction.

Purpose of the Study:

  • To review the classification, causes, and consequences of obstructive uropathy.
  • To explore the mechanisms underlying renal interstitial fibrosis in long-term obstructive nephropathy.
  • To highlight the potential therapeutic role of ACE inhibitors in mitigating renal fibrosis.

Main Methods:

  • Literature review of obstructive nephropathy and uropathy.
  • Analysis of factors contributing to renal interstitial fibrosis.

Related Experiment Videos

  • Examination of animal study findings on ACE inhibitors.

    • Main Results:

    • Obstruction impairs renal blood flow, GFR, and tubular functions, including solute/water reabsorption and urine concentration.
    • Long-term obstructive uropathy is associated with renal interstitial fibrosis, involving macrophages, growth factors, hypoxia, and cytokines.
    • Animal studies indicate that ACE inhibitors can reduce interstitial fibrosis in obstructive uropathy models.

    Conclusions:

    • Obstructive nephropathy is a treatable condition with diverse causes and significant impact on renal function.
    • Renal interstitial fibrosis is a key pathological outcome of chronic obstruction.
    • ACE inhibitors show promise in ameliorating renal fibrosis associated with obstructive uropathy.